Article in Nature’s Scientific Reports: Machine learning approaches to predict lupus disease activity from gene expression data

Released today, July 3, 2019, in Nature’s Scientific Reportswww.nature.com/articles/s41598-019-45989-0: AMPEL BioSolutions shows a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat chronic disease.  The article details our machine learning approach to predict disease activity from gene data obtained from patient blood samples, the lab test, only a concept for the last few years, is now ready for development for practical use.

NBC12 Digital Dialogue for Lupus Awareness Month

For Lupus Awareness Month in May, NBC12 hosted a Digital Dialogue Tuesday night featuring advocates and specialists in the Lupus field, treatment, coping with the disease, finding a cure and new advancements being pioneered right here in Virginia. The Dialogue included AMPEL COO & CSO, Dr Amrie Grammer.

Watch the full program with host Kelly Avellino here: https://www.nbc12.com/2019/05/24/digital-dialogue-lupus-awareness-month/